Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06070714 · ClinicalTrials.gov registry record · NA

Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT06070714: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT06070714 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 178 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06070714, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

This is a prospective randomized controlled trial designed to assess the efficacy and safety of Lumenis® Pulse™ P120H holmium laser system with the Moses technology (holmium laser with pulse modulation) versus the Soltive™ SuperPulsed Laser System with the thulium fiber laser (thulium fiber laser), in dusting of renal stones during ureteroscopy with laser lithotripsy. 310 participants will be enrolled across 5 research sites.

Primary Outcome

The primary objective of this study is to compare the stone free rate as determined by ultra-low dose limited renal CT at 2 months post operatively between the holmium laser with pulse modulation and the thulium fiber laser.

Interventions

  • DEVICE Holmium laser with pulse modulation
  • DEVICE Thulium fiber laser

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2023-09-07
Est. Completion 2025-10-31
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT06070714 record still lists

NCT06070714 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 2 interventions - of which Holmium laser with pulse modulation is the first listed.

NCT06070714 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06070714 about?

NCT06070714 is a clinical study titled "Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Fiber Laser on Renal Stones". This is a prospective randomized controlled trial designed to assess the efficacy and safety of Lumenis® Pulse™ P120H holmium laser system with the Moses technology (holmium laser with pulse modulation) versus the Soltive™ SuperPulsed Laser System with the thulium fiber laser (thulium fiber laser), ...

What is the current status of trial NCT06070714?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2023-09-07. Estimated completion is 2025-10-31.

What interventions are being tested in trial NCT06070714?

The interventions under investigation include: Holmium laser with pulse modulation (DEVICE), Thulium fiber laser (DEVICE).

Who is sponsoring clinical trial NCT06070714?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06070714's enrollment target sits among peer trials

178 604th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06070714, the US trial registry maintained by the National Library of Medicine. NCT06070714 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.